According to 10x Genomics 's latest financial reports and stock price the company's current number of shares outstanding is 122,606,091. At the end of 2025 the company had 122,606,091 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 0.12 B | 0.83% |
2024 | 0.12 B | 2.56% |
2023 | 0.11 B | 3.32% |
2022 | 0.11 B | 2.56% |
2021 | 0.11 B | 4.2% |
2020 | 0.10 B | 11.83% |
2019 | 96.02 M | 15.85% |
2018 | 82.89 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | 110,281,832 | -10.05% | Jersey |
![]() Novavax NVAX | 161,049,000 | 31.35% | ๐บ๐ธ USA |
![]() Organovo ONVO | 1,504,713 | -98.77% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | 22,838,856 | -81.37% | ๐ฌ๐ง UK |